Our Services
Medical Information
Helpful Resources
Published on: 9/22/2026
Methylprednisolone is a corticosteroid used to reduce inflammation and calm an overactive immune system in conditions such as asthma flares, severe allergic reactions, rheumatoid arthritis, lupus, inflammatory bowel disease, skin disorders, multiple sclerosis relapses, and certain cancers. Common side effects include increased appetite and weight gain, fluid retention, trouble sleeping, mood or energy changes, indigestion, elevated blood sugar, and higher infection risk, while longer use raises concerns like bone thinning, high blood pressure, and adrenal suppression. Dose, duration, and your other health conditions all change what to expect, so there are several important factors to consider below before assuming a symptom is harmless or drug related.
If you are unsure whether what you are feeling is a medication side effect, the underlying condition flaring, or something separate that needs attention, a free, instant, online symptom check can help you organize your symptoms and understand likely explanations in minutes. Use it to decide how urgently to act and to walk into your next appointment with clear, specific information instead of guesswork.
Last reviewed for medical accuracy: 09/22/2026
Methylprednisolone is a synthetic corticosteroid prescribed to reduce inflammation and suppress immune responses. It mimics the action of hormones naturally produced by the adrenal glands. Healthcare providers often choose methylprednisolone when other treatments aren’t effective or fast enough.
Common uses include:
Methylprednisolone can be given by mouth (tablet or oral solution), injected into a muscle, vein, or directly into a joint. Your doctor will choose the form and dose based on your condition, severity, and how you respond to treatment.
Methylprednisolone binds to glucocorticoid receptors inside cells, altering gene expression. This process:
Because of these effects, methylprednisolone can provide quick relief from pain, swelling, redness, and itching. However, suppressing the immune response also means you may be more vulnerable to infections.
Most people tolerate methylprednisolone well when it’s used short-term. Common side effects include:
These side effects often improve once your body adjusts or when your dose is tapered. If they persist or become bothersome, talk with your doctor about ways to manage them.
While rare, some effects can be more serious. Contact your healthcare provider if you experience any of the following:
Because methylprednisolone can unmask or worsen certain conditions, it’s crucial to follow your doctor’s instructions closely.
Longer courses or higher doses of methylprednisolone pose additional risks. These include:
If you’re on methylprednisolone for weeks or months, your doctor may recommend:
Never stop taking methylprednisolone suddenly without medical guidance. Abrupt discontinuation can lead to adrenal crisis—a life-threatening condition.
To help reduce the chance of complications:
Always keep a list of all medications and supplements you’re taking, and share it with your healthcare team.
While most side effects can be managed, certain symptoms require prompt evaluation. Seek emergency care or call your doctor if you experience:
If you’re unsure whether your symptoms are serious, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker: https://ubiehealth.com/.
Your doctor will schedule periodic visits to:
Open communication with your healthcare team is vital. Mention any new or worsening symptoms right away.
Methylprednisolone offers powerful anti-inflammatory and immunosuppressive benefits for a wide range of conditions. While common side effects tend to be mild and manageable, more serious issues can arise, especially with long-term use. Always follow your doctor’s instructions and report any concerning symptoms without delay.
For life-threatening or severe problems, please speak to a doctor or visit the nearest emergency department. Your health is too important to ignore potentially serious symptoms.
(References)
* Fernández S, Reaño M, Vives R, Borja J, Daroca P, Canto G, Rodríguez J. 6-Methylprednisolone-induced bronchospasm. Allergy. 1997 Jul;52(7):780-2. doi: 10.1111/j.1398-9995.1997.tb01242.x. PMID: 9265999.
* Mechelli S, Bolognesi S, Siuti E, Stefanelli A, Castiglioni MG. [Methimazole-induced aplastic anemia]. Recenti Prog Med. 1999 Sep;90(9):470-2. PMID: 10544668.
* Mutarelli EG, Adoni T. Iatrogenic meningitis. Arq Neuropsiquiatr. 2013 Sep;71(9B):659-60. doi: 10.1590/0004-282X20130145. PMID: 24141499.
* Malani AN, Kerr L, Obear J, Singal B, Kauffman CA. Alopecia and nail changes associated with voriconazole therapy. Clin Infect Dis. 2014 Aug 1;59(3):e61-5. doi: 10.1093/cid/ciu275. Epub 2014 May 22. PMID: 24855150.
* Sevuk U, Baysal E, Altindag R, Yaylak B, Adiyaman MS, Ay N, Beyazit U, Alp V. Role of methylprednisolone in the prevention of postpericardiotomy syndrome after cardiac surgery. Eur Rev Med Pharmacol Sci. 2016;20(3):514-9. PMID: 26914128.
* Boz C, Terzi M, Zengin Karahan S, Sen S, Sarac Y, Emrah Mavis M. Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis. Mult Scler. 2018 Aug;24(9):1205-1211. doi: 10.1177/1352458517717806. Epub 2017 Jun 26. PMID: 28649909.
* Danielson M, Reinsfelt B, Westerlind A, Zetterberg H, Blennow K, Ricksten SE. Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial. J Neuroinflammation. 2018 Sep 27;15(1):283. doi: 10.1186/s12974-018-1318-y. Epub 2018 Sep 27. PMID: 30261896; PMCID: PMC6158839.
* Pekmezci E. A novel triple combination in treatment of melasma: Significant outcome with far less actives. J Cosmet Dermatol. 2019 Dec;18(6):1700-1704. doi: 10.1111/jocd.12904. Epub 2019 Mar 28. PMID: 30920111.
* Dong H, He Z, Cai S, Ma H, Su L, Li J, Yang H, Xie R. Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury. J Nanobiotechnology. 2025 Feb 8;23(1):98. doi: 10.1186/s12951-025-03153-z. Epub 2025 Feb 8. PMID: 39923070; PMCID: PMC11807324.
* Sunthankar SD, Hill KD, Jacobs JP, Baldwin HS, Jacobs ML, Li JS, Graham EM, Blasiole B, Husain SA, Bleiweis MS, Mettler B, Benscoter A, Wald E, Karamlou T, Van Bergen AH, Eghtesady P, Scott JP, Anderson BR, Alfieris G, Vener DF, Kannankeril PJ. Methylprednisolone for Infant Heart Surgery: Subpopulation Analyses of a Randomized Controlled Trial. Crit Care Med. 2025 Jul 1;53(7):e1470-e1480. doi: 10.1097/CCM.0000000000006721. Epub 2025 May 21. PMID: 40396812; PMCID: PMC12378003.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.